TLR4 and colorectal cancer: Reducing IL-6 and TNF-α expression and infiltration of pro-inflammatory macrophages, remodeling gut microbiota composition and bile acid metabolism to inhibit the TLR4/MyD 88 pathway, and thereby inhibiting colorectal cancer associated with a high-fat diet.